JPRN-jRCT2080222010未知3 期
An Extension Study in Subjects with Plaque Psoriasis
Kyowa Hakko Kirin Co., Ltd.0 个研究点目标入组 100 人开始时间: 2013年1月28日最近更新:
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 70age old（—）
- 性别
- All
入选标准
- •Subject has voluntarily signed the written informed consent form to participate in this study
- •- Subject has completed the week 12 evaluation of Study 4827-002
排除标准
- •- Subject has had a serious infection, defined as requiring systemic treatment with antibiotics or antivirals (excluding oral administration)
- •- Subject has been judged to be ineligible for participation in the study by the investigators/subinbestigators
研究者
相似试验
未知
3 期
M518101 phase III study in plaque psoriasis patientsPlaque psoriasisJPRN-jRCT2080222894Maruho Co.,Ltd.
未知
2 期
M518101 phase 2b study in plaque psoriasis patients - comparison study 2Plaque psoriasisJPRN-jRCT2080221434Maruho Co.,Ltd.
未知
2 期
M518101 phase 2b study in plaque psoriasis patients - comparison study 1Plaque psoriasisJPRN-jRCT2080221433Maruho Co.,Ltd.
未知
2 期
M518101 phase 2b study in plaque psoriasis patients - comparison study 3Plaque psoriasisJPRN-jRCT2080222091Maruho Co.,Ltd.
已完成
不适用
A Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study)Moderate Plaque PsoriasisNCT03059953Genesis Pharma S.A.302